Diabetes in chronic liver disease: from old concepts to new evidence (Q36408704)

14 August 2017

1 reference

title

Diabetes in chronic liver disease: from old concepts to new evidence (English)

1 reference

Umberto Vespasiani Gentilucci

14 August 2017

1 reference

chronic liver disease

0 references

author

object named as

Umberto Vespasiani Gentilucci

3

0 references

Antonio Picardi

object named as

Antonio Picardi

1

0 references

author name string

Delia D'Avola

2

1 reference

14 August 2017

Giovanni Galati

4

1 reference

14 August 2017

Enrica Fiori

5

1 reference

14 August 2017

Sandro Spataro

6

1 reference

14 August 2017

Antonella Afeltra

7

1 reference

14 August 2017

1 July 2006

1 reference

Diabetes - Metabolism: Research and Reviews

14 August 2017

1 reference

14 August 2017

22

1 reference

14 August 2017

4

1 reference

14 August 2017

274-283

1 reference

Novel concepts in insulin regulation of hepatic gluconeogenesis

14 August 2017

1 reference

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis

21 January 2018

1 reference

Kupffer cells play a major role in insulin-mediated hepatic glucose uptake in vivo

21 January 2018

1 reference

7 January 2021

Insulin binding and degradation by rat liver Kupffer and endothelial cells

1 reference

7 January 2021

Insulin signalling: metabolic pathways and mechanisms for specificity

1 reference

7 January 2021

Molecular mechanisms of insulin resistance

1 reference

7 January 2021

Insulin resistance and chronic cardiovascular inflammatory syndrome

1 reference

7 January 2021

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation

1 reference

7 January 2021

Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation

1 reference

7 January 2021

TNF-alpha and growth hormone resistance in patients with chronic liver disease.

1 reference

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

7 January 2021

Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis.

1 reference

7 January 2021

Glucose and insulin metabolism in cirrhosis

1 reference

7 January 2021

Degradation and Secretion of Insulin in Hepatic Cirrhosis

1 reference

7 January 2021

Insulin resistance in noncirrhotic idiopathic portal hypertension

1 reference

7 January 2021

Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus

1 reference

7 January 2021

Diabetes mellitus and alcohol

1 reference

7 January 2021

Alcohol intake and incidence of type 2 diabetes in men.

1 reference

7 January 2021

Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance

1 reference

7 January 2021

Ethanol stimulates glycogenolysis and inhibits both glycogenesis via gluconeogenesis and from exogenous glucose in perfused rat liver

1 reference

7 January 2021

Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation

1 reference

7 January 2021

Ethanol, oxidative stress, and cytokine-induced liver cell injury

1 reference

7 January 2021

Oxidative stress: does it 'initiate' hepatic stellate cell activation or only 'perpetuate' the process?

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

7 January 2021

The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity

1 reference

7 January 2021

Insulin resistance in type 2 diabetes: role of fatty acids

1 reference

7 January 2021

Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling

1 reference

7 January 2021

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

7 January 2021

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

7 January 2021

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

7 January 2021

High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells

1 reference

7 January 2021

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis

1 reference

7 January 2021

High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury

1 reference

7 January 2021

Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Hepatitis C: a metabolic liver disease

1 reference

7 January 2021

Insulin resistance and insulin secretion in chronic hepatitis C virus infection

1 reference

7 January 2021

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

1 reference

7 January 2021

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

7 January 2021

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

7 January 2021

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

1 reference

7 January 2021

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

7 January 2021

Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein

1 reference

7 January 2021

Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions

1 reference

7 January 2021

Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis

1 reference

7 January 2021

Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety.

1 reference

7 January 2021

Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment

1 reference

7 January 2021

Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease.

1 reference

7 January 2021

Regulation of insulin-like growth factor binding protein-1 during protracted critical illness

1 reference

7 January 2021

High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance

1 reference

7 January 2021

Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

1 reference

7 January 2021

Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells

1 reference

7 January 2021

Infliximab reverses growth hormone resistance associated with inflammatory bowel disease

1 reference

7 January 2021

The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.

1 reference

7 January 2021

Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene

1 reference

7 January 2021

GH treatment in adults with chronic liver disease: a randomized, double-blind, placebo-controlled, cross-over study

1 reference

7 January 2021

Growth hormone-induced alterations in the insulin-signaling system

1 reference

7 January 2021

Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance

1 reference

7 January 2021

Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes

1 reference

7 January 2021

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

7 January 2021

TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad

1 reference

7 January 2021

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

1 reference

7 January 2021

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

7 January 2021

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.636

1 reference

14 August 2017

1 reference